Publications

Prevalence of persistent SARS-CoV-2 in a large community surveillance study.

Ghafari M. et al, (2024), Nature

HIV transmission dynamics and population-wide drug resistance in rural South Africa.

Gupta R. et al, (2023), Res Sq

Population dynamics of HIV drug resistance among pre-treatment and treatment-experienced persons with HIV during treatment scale-up in Uganda: a population-based longitudinal study

Martin MA. et al, (2023)

Atypical B cells and impaired SARS-CoV-2 neutralization following heterologous vaccination in the elderly.

Ferreira IATM. et al, (2023), Cell reports, 42

Limited emergence of resistance to integrase strand transfer inhibitors (INSTIs) in ART-experienced participants failing dolutegravir-based antiretroviral therapy: a cross-sectional analysis of a Northeast Nigerian cohort.

Abdullahi A. et al, (2023), The Journal of antimicrobial chemotherapy, 78, 2000 - 2007

HIV escape and resistance in the central nervous system in treatment experienced South Africans

Collier D. et al, (2023)

SARS-COV-2 antibody responses to AZD1222 vaccination in West Africa.

Abdullahi A. et al, (2022), Nature communications, 13

Author Correction: SARS-CoV-2 evolution during treatment of chronic infection.

Kemp SA. et al, (2022), Nature, 608

Author Correction: Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies.

Collier DA. et al, (2022), Nature, 608

SARS-CoV-2 Antibody Responses to AZD1222 Vaccination in West Africa

Abdullahi A. et al, (2022)

HIV-1 Evolutionary Dynamics under Nonsuppressive Antiretroviral Therapy.

Kemp SA. et al, (2022), mBio, 13

Transmission of B.1.617.2 Delta variant between vaccinated healthcare workers.

Kemp SA. et al, (2022), Scientific reports, 12

Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity.

Meng B. et al, (2022), Nature, 603, 706 - 714

Transmission of B.1.617.2 Delta Variant Between Vaccinated Healthcare Workers

Kemp SA. et al, (2022)

Antibody responses to AZD1222 vaccination in West Africa

Abdullahi A. et al, (2022)

Atypical B cells and impaired SARS-CoV-2 neutralisation following booster vaccination in the elderly

Ferreira IATM. et al, (2022)

Limited emergence of resistance to Integrase strand transfer inhibitors (INSTIs) in HIV-experienced patients failing dolutegravir-based antiretroviral therapy: Cross-sectional analysis from a Northeast Nigerian cohort

Abdullahi A. et al, (2022)

Transmission of B.1.617.2 Delta Variant between vaccinated healthcare workers

Kemp SA. et al, (2021)

SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion

Mlcochova P. et al, (2021), Nature, 599, 114 - 119

SARS-CoV-2 B.1.617 Mutations L452R and E484Q Are Not Synergistic for Antibody Evasion.

Ferreira IATM. et al, (2021), The Journal of infectious diseases, 224, 989 - 994

Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7

Meng B. et al, (2021), Cell Reports, 35, 109292 - 109292

Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies

Collier DA. et al, (2021), Nature, 593, 136 - 141

SARS-CoV-2 evolution during treatment of chronic infection

Kemp SA. et al, (2021), Nature, 592, 277 - 282

Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation.

Halpin SJ. et al, (2021), Journal of medical virology, 93, 1013 - 1022

SARS-CoV-2 B.1.1.7 sensitivity to mRNA vaccine-elicited, convalescent and monoclonal antibodies

Collier DA. et al, (2021)

Recurrent independent emergence and transmission of SARS-CoV-2 Spike amino acid H69/V70 deletions

Gupta R. et al, (2021)

A Cross-Sectional Survey of the Knowledge, Attitudes, and Practices of Antimicrobial Users and Providers in an Area of High-Density Livestock-Human Population in Western Kenya.

Kemp SA. et al, (2021), Frontiers in veterinary science, 8

A Cross-Sectional Survey of the Knowledge, Attitudes & Practices of Antimicrobial Users and Providers in an Area of High-Density Livestock-Human Population in Western Kenya

Kemp S. et al, (2021)

HIV-1 evolutionary dynamics under non-suppressive antiretroviral therapy

Kemp S. et al, (2021)

Recurrent Emergence and Transmission of a SARS-CoV-2 Spike Deletion H69/V70

Kemp SA. et al, (2021)

SARS-CoV-2 B.1.617.2 Delta variant replication, sensitivity to neutralising antibodies and vaccine breakthrough

Mlcochova P. et al, (2021)

SARS-CoV-2 Omicron spike mediated immune escape and tropism shift

Meng B. et al, (2021)

Neutralising antibodies in Spike mediated SARS-CoV-2 adaptation.

Kemp SA. et al, (2020), medRxiv

Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase.

Siedner MJ. et al, (2020), Nature communications, 11

In Vivo Emergence of a Novel Protease Inhibitor Resistance Signature in HIV-1 Matrix.

Datir R. et al, (2020), mBio, 11, e02036 - e02020

High prevalence of integrase mutation L74I in West African HIV-1 subtypes prior to integrase inhibitor treatment

El Bouzidi K. et al, (2020), Journal of Antimicrobial Chemotherapy

Recurrent emergence and transmission of a SARS-CoV-2 spike deletion H69/V70

Kemp S. et al, (2020)

In Vivo Emergence of a Novel Protease Inhibitor Resistance Signature in HIV-1 Matrix

Datir R. et al, (2019)

Cookies on this website

Publications